The initial public offering (IPO) for specialty chemicals manufacturer Prasol Chemicals opened for subscription today, September 8, allowing investors to bid for shares within a price band of Rs 643-676 apiece. The company aims to raise Rs 500 crore through this offering, which will conclude on Thursday, September 10.
IPO Details and Structure
The Prasol Chemicals IPO comprises a fresh issue of Rs 80 crore and an offer-for-sale (OFS) of up to Rs 420 crore by its promoters and existing shareholders. The fresh proceeds are earmarked primarily for debt repayment, which is expected to further strengthen the company's balance sheet. Investors can apply for a minimum of 22 equity shares, with bids accepted in multiples thereafter.
Ahead of its public debut, Prasol Chemicals successfully garnered Rs 150 crore from 14 anchor investors, allocating 22,18,930 equity shares at the upper price band of Rs 676 per share. Notable anchor investors included Nuvama Multi Asset Strategy, Clarus Capital I, and Aditya Birla Life Insurance.
Company Profile and Financial Performance
Incorporated in 1992 and based in Thane, Prasol Chemicals is a diversified player in the specialty chemicals sector. It is recognized as India's sole manufacturer of isophorone and boasts a portfolio of over 150 specialty chemicals, including acetone-based and phosphorous-based compounds. The company serves more than 1,600 customers and exports its products to 69 countries, highlighting a strong global presence.
Prasol Chemicals has demonstrated robust financial growth, reporting a revenue, EBITDA, and PAT CAGR of 18.6%, 51.7%, and 97.8% respectively between FY24 and FY26. For the financial year ended March 31, 2026, the company recorded a net profit of Rs 83.12 crore on a revenue of Rs 1,237.85 crore. Its net profit for FY25 stood at Rs 43.57 crore with revenue of Rs 1,015.54 crore. At the current valuations, the company is expected to command a market capitalization exceeding Rs 4,000 crore.
Analyst Recommendations and Valuation
Analysts have largely responded positively to the Prasol Chemicals IPO, with many recommending a 'subscribe' rating for long-term investment. SBI Securities, Anand Rathi, Master Capital Services, and Ventura cited healthy return ratios, sound financials, significant entry barriers in its niche market, and a diversified global customer base as key strengths. The company's proposed expansion at Saykha, Gujarat, is also seen as a catalyst for future growth.
However, some analysts, like Swastika Investmart, expressed caution, noting concerns over low capacity utilization, a substantial offer-for-sale component, and what they perceive as rich valuations. The issue is valued at an FY26 P/E multiple of 48.1x based on post-issue capital. Swastika Investmart assigned a 'neutral' rating, suggesting investors might consider the stock post-listing once financial performance stabilizes and valuations become more reasonable.
Grey Market Premium (GMP) and Investor Reservations
In the grey market, Prasol Chemicals shares were last heard commanding a premium of Rs 55 apiece, indicating potential listing gains of approximately 8% for investors. The IPO has reserved 50% of its shares for Qualified Institutional Bidders (QIBs), 15% for Non-Institutional Investors (NIIs), and 15% for retail investors.
DAM Capital Advisors is the sole book running lead manager for the issue, with Kfin Technologies serving as the official registrar.